Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zero Candida Technologies is a FemTech medical device company developing an AI-driven, tampon-like device that uses therapeutic blue light for the non-drug treatment of vulvo-vaginal candidiasis (VVC) by targeting Candida fungus. The device is in a pre-clinical stage, having completed large animal safety trials with demonstrated high efficacy. Human pilot clinical trials are planned for late 2026 in Israel, with further clinical expansion in the U.S. targeted for 2027. The device also has diagnostic capabilities and is designed for at-home care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zero Candida Technologies.